News About: Pharm. Industry
Top 100 companies made 86% of total pharmaceutical production in 2003.
The 2003 pharmaceutical production report revealed 9,532,400 million won in total, which shared with 86.5% by the top 100 companies at 8,245,000 million won, 65.5% by the top 50 at 6,242,200 million won, 51.9% by the ...
Organon Korea, Janssen Korea co-promote oral antidepressant Remeron SolTab
Organon Korea said that it has contracted with Janssen Korea to co-promote in Korea Remeron SolTab (mirtazapine), an orally disintegrating tablet that has been approved for the treatment of depression. It was develope...
Aventis to launch Ketec, an antibiotic in July.
Aventis will launch Ketec (Telythromycin), an oral antibiotic, in the market from July 1 for the first time over the world, which was specifically developed for the treatment of regional acquired respiratory tract inf...
Boryung to introduce wellbeing drink, Amino Plus.Boryung introduced a wellbeing drink preparation, Amino Plus, formulated with 11 amino acids, vitamin B1 and B2 for the recovery of fatigue and exhausted body conditions.
It ...
|
Korea's drug output totaled 9.5 trillion won in 2003
Korea's total drug production by 679 manufacturers was 9.5 trillion won in 2003, up 3.65 percent compared with 9.1 trillion won a year earlier, according to data from the Korea Pharmaceutical Manufacturers Association...
Many Korean pharmaceutical firms want to enter glimepiride market
In coming autumn, Hadok-Aventis Pharma will face an uphill battle in trying to protect its glimepiride market from domestic competition as 33 generic items of Amaryl (glimepiride), an oral antidiabetic agent, received...
GSK to launch Paxil CR in July
GSK unveiled its plan to launch Paxil (paroxetine HCl) controlled release tablet (12.5 mg) in July, which belongs to a class of the selective serotonin reuptake inhibitors (SSRIs) having broad range of efficacy in moo...
Mobile device DiabeticPhone to launch in pharmacy market.A new conceptual device for the control of diabetic management will be launched into the retail pharmacy market under the brand of "DiabeticPhone", which may keenly attract inte...
|
Korean pharmaceutical firms challenge Pfizer's Norvasc
Korean major pharmaceutical markers are set to challenge Pfizer's current lead in the domestic amlodipine market by strategically launching their novel amlopdipine salts for sales boost, according to industry sources ...
Pharmacy community denouncing drug wholesalers on puffed prices.
It was found that a wholesaler supplied drugs at puffed prices to a retail pharmacy, which gave serious business damages. When the pharmacy legally claimed and rejected its credit payment, the wholesaler counter attac...
